Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 29, 2016
On Wednesday, February 24th, the United States Senate confirmed the nomination of Robert Califf, M.D. to be Commissioner of Food and Drugs. Dr. Califf was sworn into office on February 25th.
read more
Wednesday, April 10, 2024
Sen-Jam Pharmaceutical has entered a third strategic partnership with KVK-Tech. KVK-Tech is a Specialty Pharmaceutical Manufacturing company that will be providing formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam's first ...
read more
Thursday, December 11, 2025
Sen-Jam Pharmaceutical announced a partnership with TASK Clinical, a global contract research organization (CRO). Under the agreement, TASK Clinical will fund two-thirds of the upcoming Phase 3 clinical trial for SJP-001 in exchange for equity.
read more
Selvita announced it plans to separate into two companies.
read more
Selvita Inc., the US subsidiary of Selvita S.A., headquartered in Cambridge, MA, has initiated a medicinal chemistry collaboration with the University of California, San Francisco (UCSF).
read more
Selvita S.A., a biotechnology company from Krakow, Poland (PL:SLV) announced today that its collaboration with Orion Corporation from Espoo, Finland (ORNBV) on SEL103 program, for the symptomatic treatment of Alzheimer’s disease has reached the main ...
read more
Sandra Lueken has assumed the role of Vice President, Head of Quality & Regulatory Affairs
read more
Selkirk Pharma, Inc. announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of Selkirk Pharma...
read more
Friday, February 16, 2024
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, announced the Aseptic Process Simulation (APS) qualification of its ...
read more
Tuesday, September 26, 2017
Selexis and OSE announced the signing of two CLAs that provide OSE with access to high-performance RCBs developed using the Selexis SUREtechnology Platform.
read more
Wednesday, September 26, 2018
Selexis SA and Hoba Therapeutics announced they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 for peripheral neuropathic pain.
read more
Wednesday, January 09, 2019
Selexis has signed additional CLAs with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, and adoptive cell therapies.
read more
Selexis SA and KBI Biopharm, announced that they have signed service agreements with Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies.
read more
Sekisui XenoTech's Analytical Services lab provides researchers with custom method development and method validation, dose solution analysis, in vitro and in vivo metabolite profiling studies.
read more
Sekisui XenoTech has been awarded US patent # 10,001,471 “In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes.”
read more